Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/12/2016
Hutchinson Area Health Care
mi
from
Hutchinson, MN
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/12/2016
Hutchinson Area Health Care
mi
from
Hutchinson, MN
Click here to add this to my saved trials
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/12/2016
Meeker County Memorial Hospital
mi
from
Lichfield, MN
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/12/2016
Meeker County Memorial Hospital
mi
from
Lichfield, MN
Click here to add this to my saved trials
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/12/2016
HealthEast Cancer Care at St. John's Hospital
mi
from
Maplewood, MN
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/12/2016
HealthEast Cancer Care at St. John's Hospital
mi
from
Maplewood, MN
Click here to add this to my saved trials
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/12/2016
Minnesota Oncology Hematology PA-Maplewood
mi
from
Maplewood, MN
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/12/2016
Minnesota Oncology Hematology PA-Maplewood
mi
from
Maplewood, MN
Click here to add this to my saved trials
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/12/2016
Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
mi
from
Minneapolis, MN
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/12/2016
Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/12/2016
Hennepin County Medical Center - Minneapolis
mi
from
Minneapolis, MN
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/12/2016
Hennepin County Medical Center - Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/12/2016
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/12/2016
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/12/2016
St. Francis Cancer Center at St. Francis Medical Center
mi
from
Shakopee, MN
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/12/2016
St. Francis Cancer Center at St. Francis Medical Center
mi
from
Shakopee, MN
Click here to add this to my saved trials
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/12/2016
HealthEast Cancer Care at St. Joseph's Hospital
mi
from
St Paul, MN
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/12/2016
HealthEast Cancer Care at St. Joseph's Hospital
mi
from
St Paul, MN
Click here to add this to my saved trials
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/12/2016
United Hospital
mi
from
St. Paul, MN
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/12/2016
United Hospital
mi
from
St. Paul, MN
Click here to add this to my saved trials
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/12/2016
HealthEast Cancer Care at Woodwinds Health Campus
mi
from
Woodbury, MN
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/12/2016
HealthEast Cancer Care at Woodwinds Health Campus
mi
from
Woodbury, MN
Click here to add this to my saved trials
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated:  7/12/2016
Minnesota Oncology and Hematology PA-Woodbury
mi
from
Woodbury, MN
(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Status: Enrolling
Updated: 7/12/2016
Minnesota Oncology and Hematology PA-Woodbury
mi
from
Woodbury, MN
Click here to add this to my saved trials
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated:  7/12/2016
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated: 7/12/2016
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated:  7/12/2016
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated: 7/12/2016
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated:  7/12/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated: 7/12/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated:  7/12/2016
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated: 7/12/2016
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated:  7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated: 7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated:  7/12/2016
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated: 7/12/2016
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated:  7/12/2016
CCOP - Wichita
mi
from
Wichita, KA
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated: 7/12/2016
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated:  7/12/2016
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated: 7/12/2016
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated:  7/12/2016
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated: 7/12/2016
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated:  7/12/2016
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated: 7/12/2016
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated:  7/12/2016
Medcenter One Health System
mi
from
Bismarck, ND
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated: 7/12/2016
Medcenter One Health System
mi
from
Bismarck, ND
Click here to add this to my saved trials
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated:  7/12/2016
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated: 7/12/2016
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated:  7/12/2016
CCOP - Dayton
mi
from
Dayton, OH
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated: 7/12/2016
CCOP - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated:  7/12/2016
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated: 7/12/2016
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated:  7/12/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated: 7/12/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated:  7/12/2016
CCOP - St. Vincent Hospital Cancer Center, Green Bay
mi
from
Green Bay, WI
Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
The Use of Low Dose Testosterone To Enhance Libido In Female Cancer Survivors: A Phase III Randomized, Placebo-Controlled, Double-Blind Crossover Study
Status: Enrolling
Updated: 7/12/2016
CCOP - St. Vincent Hospital Cancer Center, Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
Therapy of Myeloid Metaplasia-Myelofibrosis, Atypical Chronic Myeloid or Myelomonocytic Leukemia, C-Kit Positive Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (AML-MDS), Hypereosinophilic Syndrome, Polycythemia Vera, and Mastocytosis With Dasatinib (BMS-354825)
Status: Enrolling
Updated:  7/12/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
Therapy of Myeloid Metaplasia-Myelofibrosis, Atypical Chronic Myeloid or Myelomonocytic Leukemia, C-Kit Positive Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (AML-MDS), Hypereosinophilic Syndrome, Polycythemia Vera, and Mastocytosis With Dasatinib (BMS-354825)
Status: Enrolling
Updated: 7/12/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated:  7/12/2016
Elkhart General Hospital
mi
from
Elkhart, IN
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated: 7/12/2016
Elkhart General Hospital
mi
from
Elkhart, IN
Click here to add this to my saved trials
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated:  7/12/2016
Howard Community Hospital
mi
from
Kokomo, IN
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated: 7/12/2016
Howard Community Hospital
mi
from
Kokomo, IN
Click here to add this to my saved trials
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated:  7/12/2016
Center for Cancer Therapy at LaPorte Hospital and Health Services
mi
from
La Porte, IN
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated: 7/12/2016
Center for Cancer Therapy at LaPorte Hospital and Health Services
mi
from
La Porte, IN
Click here to add this to my saved trials
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Northern Indiana CR Consortium
mi
from
South Bend, IN
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Northern Indiana CR Consortium
mi
from
South Bend, IN
Click here to add this to my saved trials
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated:  7/12/2016
Memorial Hospital of South Bend
mi
from
South Bend, IN
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated: 7/12/2016
Memorial Hospital of South Bend
mi
from
South Bend, IN
Click here to add this to my saved trials
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated:  7/12/2016
Michiana Hematology Oncology
mi
from
South Bend, IN
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated: 7/12/2016
Michiana Hematology Oncology
mi
from
South Bend, IN
Click here to add this to my saved trials
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated:  7/12/2016
Saint Joseph Regional Medical Center
mi
from
South Bend, IN
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated: 7/12/2016
Saint Joseph Regional Medical Center
mi
from
South Bend, IN
Click here to add this to my saved trials
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated:  7/12/2016
Lakeland Regional Cancer Care Center - St. Joseph
mi
from
St. Joseph, MI
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated: 7/12/2016
Lakeland Regional Cancer Care Center - St. Joseph
mi
from
St. Joseph, MI
Click here to add this to my saved trials
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated:  7/12/2016
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated: 7/12/2016
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Click here to add this to my saved trials
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated:  7/12/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated: 7/12/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Click here to add this to my saved trials
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated:  7/12/2016
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
Status: Enrolling
Updated: 7/12/2016
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
MBCCOP - Medical College of Georgia Cancer Center
mi
from
Augusta, GA
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
MBCCOP - Medical College of Georgia Cancer Center
mi
from
Augusta, GA
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Rush-Copley Cancer Care Center
mi
from
Aurora, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
St. Joseph Medical Center
mi
from
Bloomington, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
St. Joseph Medical Center
mi
from
Bloomington, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Graham Hospital
mi
from
Canton, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Graham Hospital
mi
from
Canton, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Memorial Hospital
mi
from
Carthage, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Memorial Hospital
mi
from
Carthage, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
St. Anthony's Memorial Hospital
mi
from
Effingham, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
St. Anthony's Memorial Hospital
mi
from
Effingham, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Eureka Community Hospital
mi
from
Eureka, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Eureka Community Hospital
mi
from
Eureka, IL
Click here to add this to my saved trials
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated:  7/12/2016
Galesburg Clinic, PC
mi
from
Galesburg, IL
Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer
Changes in Breast Density and Plasma Hormone Levels After One Year of Aromatase Inhibitor Therapy
Status: Enrolling
Updated: 7/12/2016
Galesburg Clinic, PC
mi
from
Galesburg, IL
Click here to add this to my saved trials